AstraZeneca H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 Wilmington, DE HQ📍 Gaithersburg, MD most H-1B filings🌐 astrazeneca.com
Does AstraZeneca sponsor H-1B visas and green cards?
Yes. AstraZeneca has filed 1,470 H-1B LCAs and 109 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 AstraZeneca filed 255 H-1B LCAs at a median base salary of $148,838, about 22% above the national H-1B median of $121,966 for the same period, and 19 green-card cases were decided.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 104 | $155k |
| FY2025 | 151 | $145k |
| FY2024 | 124 | $149k |
| FY2023 | 130 | $144k |
| FY2022 | 159 | $129k |
| FY2021 | 299 | $125k |
| FY2020 | 213 | $125k |
| FY2019 | 95 | $106k |
| FY2018 | 115 | $100k |
| FY2017 | 80 | $96k |
A fiscal year marked partial is still in progress, so its total is lower than a complete year and the two are not comparable.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2026 (partial) | 6 | $170k |
| FY2025 | 13 | $156k |
| FY2024 | 17 | $130k |
| FY2023 | 18 | $130k |
| FY2022 | 19 | $129k |
| FY2021 | 15 | $124k |
| FY2020 | 3 | $124k |
| FY2019 | 4 | $123k |
| FY2018 | 8 | $102k |
| FY2017 | 6 | $114k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Pay against the local market
AstraZeneca’s 10 most-filed occupations and metros. Its median base salary is 126% of the local BLS median for the same work.
| Occupation | Metro | Filings | AstraZeneca pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Biochemists and Biophysicists | Washington, DC | 149 | $108,161 | $107,654 | 100% |
| Biological Scientists, All Other | Washington, DC | 97 | $119,895 | $104,101 | 115% |
| Statisticians | Washington, DC | 88 | $127,285 | $117,999 | 108% |
| Medical Scientists | Washington, DC | 86 | $162,600 | $112,681 | 144% |
| Compliance Officers | Washington, DC | 54 | $128,238 | $92,296 | 139% |
| Industrial Engineers | Washington, DC | 46 | $108,821 | $105,189 | 103% |
| Computer Occupations, All Other | Philadelphia, PA | 41 | $143,580 | $101,410 | 142% |
| Computer Occupations, All Other | Washington, DC | 40 | $147,560 | $116,797 | 126% |
| Data Scientists | Washington, DC | 35 | $173,118 | $134,855 | 128% |
| Operations Research Analysts | Washington, DC | 33 | $112,642 | $110,108 | 102% |
About AstraZeneca
AstraZeneca is a pharma & biotech company based in Cambridge, United Kingdom. It was founded in 1913 and has about 70,600 employees worldwide. It is listed on NYSE as AZN.
- Name (DOL filings)
- AstraZeneca
- Listed
- NYSE: AZN
- Incorporated in
- X0
- Headquarters
- 1 Francis Crick Avenue, Cambridge, Cb2 0aa
- Industry
- Pharma & biotech
- Employees (US, est)
- 17,843 (2024)
- Revenue FY2025
- $58.7B +9% from $54.1B
- Net income FY2025
- $10.2B +45% from $7.0B
- R&D FY2025
- $14.2B (24% of revenue)
Files 1 green-card application for every 13 H-1B filings, where a typical sponsor its size does 1 in 6.5.
AstraZeneca pays a median H-1B base of $128,616 across FY2017–2026, about 20% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to AstraZeneca
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Amgen | 3,981 | 745 | $138k | 247 | 46% |
| AbbVie | 2,407 | 562 | $147k | 146 | 77% |
| Bristol Myers Squibb | 2,250 | 441 | $153k | 145 | 83% |
| AstraZeneca | 1,470 | 255 | $149k | 95 | 43% |
| Takeda | 1,360 | 319 | $160k | 75 | 70% |
| Merck | 1,332 | 335 | $125k | 111 | 49% |
| Vertex Pharmaceuticals | 1,135 | 336 | $133k | 75 | 72% |
